Cell and Gene Therapy
Who we are
End-to-end cell and gene therapy CDMO that provides seamless innovative offerings from analytical and process development, cGMP manufacturing, and testing services at every stage for biopharmaceutical products
Vision
To accelerate the development and manufacture of advanced solutions to deliver life-changing medicines to patients
End-to-end integrated CDMO for cell and gene therapies
-
Viral Vector
AAV, Lentivirus
-
Plasmid
AAV, Lentivirus, and mRNA
-
Cell Therapy
CAR-T, TCR-T, UCAR-T, CAR-NK, DC, Stem Cell
-
Oncolytic Virus
AdV, VSV, Vaccinae, HSV
-
mRNA
mRNA and LNP